T. Rowe Price Health Sciences
(PRHSX)
50.25
+0.41
+0.82%
+0.41
+0.82%
MORE ON PRHSX
DETAILS
| Symbol | Value ($) |
|---|---|
| Morningstar Rating | |
| Previous Close | 49.84 |
| Category | Health |
| Net Assets | 6.79 Bil |
| Yield | 0.27% |
| Morningstar Risk | Average |
| Morningstar Return | High |
- Last NAV update 6/18/2013 11:30 PM ET
INVESTMENT OBJECTIVE
| NA |
|---|
| The investment seeks long-term capital appreciation. The fund normally invests at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While it can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies. The fund may invest in foreign stocks and options in keeping with the fund's objectives. |
CUMULATIVE PERFORMANCE OF $10,000
| 2009 | 2010 | 2011 | 2012 | 2013 | |
|---|---|---|---|---|---|
| Return | 32.17% | 16.33% | 11.01% | 31.93% | 21.91% |
| Value ($) | 13,217.17 | 15,375.04 | 17,067.15 | 22,517.36 | 27,450.20 |
- Year to date performance as of 6/18/2013 12:00 AM ET
MANAGEMENT & PURCHASE INFO
| Symbol | Value ($) |
|---|---|
| Fund Family | T. Rowe Price |
| Fund Manager | Taymour Tamaddon |
| Tenure (Years) | 0 |
| Fund Status | Open |
| Minimum Initial Purchase | 2,500.00 |
| Minimum IRA Investment | 1,000.00 |
| Front Load | 0.00 |
| Expense Ratio | 0.79% |
PERFORMANCE
| Symbol | Value ($) |
|---|---|
| 1 Month | -0.53% |
| 3 Months | 7.93% |
| 1 Year | 33.76% |
| 3 Years* | 26.70% |
| 5 Years* | 16.15% |
- * Annualized returns
- Performance as of 6/18/2013 12:00 AM ET
PEER COMPARISON
| PRHSX | Health | |
|---|---|---|
| 5-Yr Return | 16.15% | 13.10% |
| Sharpe Ratio | 1.71 | 2.88 |
| Net Assets | 6.79 Bil | 517.54 Mil |
| Avg Market Cap | 9.02 Bil | 19.45 Bil |
| Avg P/E | 21.26 | 21.67 |
| Portfolio Turnover | 13 | 47 |
HOLDINGS
| Symbol | Value ($) |
|---|---|
| Stocks | 94.21% |
| Cash | 5.39% |
| Fixed Income | 0.00% |
| Other | 0.40% |
TOP 10 HOLDINGS
| NAME | % NET ASSETS |
|---|---|
| Gilead Sciences Inc | 5.06% |
| Alexion Pharmaceuticals, Inc. | 4.83% |
| Catamaran Corp | 4.19% |
| Valeant Pharmaceuticals International Inc | 2.94% |
| Pharmacyclics, Inc. | 2.73% |
| Incyte Corp Ltd | 1.98% |
| UnitedHealth Group Inc | 1.92% |
| Celgene Corporation | 1.66% |
| Regeneron Pharmaceuticals, Inc. | 1.63% |
| Onyx Pharmaceuticals, Inc. | 1.57% |
DATA PROVIDERS
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
RECENT QUOTES
WATCHLIST
You're not signed in
You’re not signed in to MSN Money, so you’re seeing the Watchlist that is tied to your computer. For a more consistent Watchlist experience, sign in to MSN Money.
Learn more
Sponsored by:
MARKET UPDATE
[BRIEFING.COM] Gold, silver and natural gas rallied to new session highs this morning. Gold and silver remains near those highs with Aug gold now +0.5% at $1373.50/oz and July silver +0.2% at $21.72/oz. Aluminum futures fell 2.7% (or -$50/ton) to $17
...
More
MORE MARKET NEWS
Sponsored by:
INVESTING TIPS AND TOOLS